Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 56 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie from Lochristi, company number BE0599770992, closed financial year 2025 with a result of € 276,108 after tax. For that financial year Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie recorded a gross margin of € 395,869 and equity of € 1,000. Compared with financial year 2024, the result moved from € 196,980 to € 276,108. Profitable, and profit is growing. The buffer shrank hard: equity is 95 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ 1,000
▼ 95% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 276,108
▲ 40% vs 2024
Profit after tax over the fiscal year.
€ 169,976
▲ 227% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 276,108 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 36,614
▼ 29% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,450
▼ 60% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 31,275
▲ € 28,592 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 342,372 | € 355,976 | € 344,481 | € 395,869 | ▲ 15% |
| Profit after taxes | € 209,418 | € 214,699 | € 196,980 | € 276,108 | ▲ 40% |
| Equity | € 229,878 | € 235,159 | € 18,600 | € 1,000 | ▼ 95% |
| Total debts | € 148,411 | € 155,961 | € 211,480 | € 327,225 | ▲ 55% |
| Cash | € 111,833 | € 77,761 | € 52,011 | € 169,976 | ▲ 227% |
| Retained profit | € 211,278 | € 216,559 | € 0 | € 0 | |
| Dividend | € 128,779 | € 209,418 | € 413,538 | € 276,108 | ▼ 33% |
| Balance sheet total | € 378,289 | € 391,119 | € 230,080 | € 328,225 | ▲ 43% |
Key figures of Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie?
What happened at Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 276,108 (▲ 40% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- New establishment in Sint-Niklaas. KBO
- Start of the company according to the CBE. KBO
In short
From € 209,418 profit in 2022 to € 276,108 profit in 2025.
Paid € 278,846 in corporate taxes since 2022.
Best year ever: 2025, with € 276,108 profit.
Paid out € 1 million in dividends to the owners in total.
Management
Behind Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie are Frédérique Huysman and Siegmund Keuleers. Siegmund Keuleers is also behind MEDISCH CENTRUM WAAS.
Directors
According to the 2025 annual accounts
Frédérique Huysman
Director
Establishments
Establishment units
Physical locations of this company
Brandstraat 41
9080 Lochristi
Groenebriel 1
9000 Gent
Active since 27 February 2015
Moerlandstraat 1
9100 Sint-Niklaas
Active since 27 February 2015
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0599.770.992
- VAT number
- BE 0599.770.992
- Registered office
- Brandstraat 41, 9080 Lochristi
- Names & denominations
- Dr. Keuleers Cardiologie - Dr. Huysman Endocrinologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 February 2015
- Peppol
- Active · Active since 29 May 2025